Literature DB >> 7586160

Characterization of human buccal epithelial cells transfected with the simian virus 40 T-antigen gene.

P S Kulkarni1, K Sundqvist, C Betsholtz, P Höglund, K G Wiman, B Zhivotovsky, F Bertolero, Y Liu, R C Grafström.   

Abstract

Serum-free cultures of normal human buccal epithelial cells were transfected with a plasmid containing the SV40 T-antigen (SV40T) gene. Two major lines developed that showed extended lifespans (between 30 and 40 weeks) as compared with the controls (approximately 6 weeks). Continued growth through one or two crises generated several sublines. They expressed the epithelial marker keratin and also exhibited nuclear expression of SV40T. The lines showed abnormal karyotypes with both numerical and structural aberrations and variably responded to agents that normally inhibit growth and/or induce terminal differentiation, i.e. transforming growth factor-beta 1 and fetal bovine serum. One of the lines, termed SVpgC2a, developed into an apparently immortal line, since it had undergone more than 700 population doublings from over 2 years in culture. Further characterization of this line demonstrated its clonal origin, with integration of two copies of SV40T at the same site and the presence of both normal retinoblastoma and wild-type p53 proteins. This line showed high resistance to growth inhibition by transforming growth factor-beta 1 and serum similar to that shown by buccal carcinoma cell line SqCC/Y1. Neither SVpgC2a nor its parental lines were tumorigenic when injected into athymic nude mice, whereas the SqCC/Y1 cells induced tumors. The various lines with extended but finite lifespans, complemented by one immortalized line, which retained non-malignant properties upon extended culture, provide a battery of model systems that will be useful for studying mechanisms of human oral carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586160     DOI: 10.1093/carcin/16.10.2515

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

1.  EPS8 upregulates FOXM1 expression, enhancing cell growth and motility.

Authors:  Huixin Wang; Muy-Teck Teh; Youngmi Ji; Vyomesh Patel; Shahrzad Firouzabadian; Anisha A Patel; J Silvio Gutkind; W Andrew Yeudall
Journal:  Carcinogenesis       Date:  2010-03-29       Impact factor: 4.944

2.  Expression of alcohol dehydrogenase 3 in tissue and cultured cells from human oral mucosa.

Authors:  J J Hedberg; J O Höög; J A Nilsson; Z Xi; A Elfwing; R C Grafström
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

3.  Impact of N-Terminal Tags on De Novo Vimentin Intermediate Filament Assembly.

Authors:  Saima Usman; Hebah Aldehlawi; Thuan Khanh Ngoc Nguyen; Muy-Teck Teh; Ahmad Waseem
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

4.  FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.

Authors:  Muy-Teck Teh; Emilios Gemenetzidis; Deeviyaben Patel; Rameez Tariq; Ayesha Nadir; Adiam W Bahta; Ahmad Waseem; Iain L Hutchison
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

5.  FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.

Authors:  Emilios Gemenetzidis; Amrita Bose; Adeel M Riaz; Tracy Chaplin; Bryan D Young; Muhammad Ali; David Sugden; Johanna K Thurlow; Sok-Ching Cheong; Soo-Hwang Teo; Hong Wan; Ahmad Waseem; Eric K Parkinson; Farida Fortune; Muy-Teck Teh
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

6.  Development of oral epithelial cell line ROE2 with differentiation potential from transgenic rats harboring temperature-sensitive simian virus40 large T-antigen gene.

Authors:  Yoshiaki Tabuchi; Shigehito Wada; Mika Ikegame; Ayako Kariya; Yukihiro Furusawa; Nobuhiko Hoshi; Tatsuya Yunoki; Nobuo Suzuki; Ichiro Takasaki; Takashi Kondo; Yoshihisa Suzuki
Journal:  Exp Anim       Date:  2014
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.